Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal CO2 for Seasonal Allergic Rhinitis
NCT00917111Phase 2Completed
- Sponsor
- Capnia, Inc.
- Start
- Jul 2009
- Primary completion
- Oct 2009
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing CO2 Gas with Placebo (2 arms). Primary endpoints: Total Nasal Symptom Score at 14 days and Adverse Events at 14 days. Started Jul 2009; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00917111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917111.